 Companies seeking to slash borrowing costs on roughly US10bn of leveraged loans have pulled transactions from the market this week, as investors pushed back on opportunistic deals amid worries over the coronavirus epidemic stunting economic growth. Pharmaceutical companies Bausch Health and Pharmaceutical Product Development PPD, as well as British technology firm Micro Focus withdrew their loans from the market this week, according to three sources familiar with the deals. The decisions follow similar moves from safety firm Minimax Viking, gas firm Messer Group and energy company NorthRiver Midstream, which collectively yanked roughly US5bn from syndication last week. 